Mediwelcome Healthcare Management & Technology Inc.

SEHK:2159 Voorraadrapport

Marktkapitalisatie: HK$79.0m

Mediwelcome Healthcare Management & Technology Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Liang Wang

Algemeen directeur

CN¥691.0k

Totale compensatie

Percentage CEO-salaris86.8%
Dienstverband CEO5.2yrs
Eigendom CEO6.0%
Management gemiddelde ambtstermijn5.2yrs
Gemiddelde ambtstermijn bestuur4.5yrs

Recente managementupdates

Recent updates

There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues Despite A 25% Share Price Rise

Oct 03
There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues Despite A 25% Share Price Rise

Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Jun 18
Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Improved Revenues Required Before Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Shares Find Their Feet

Mar 06
Improved Revenues Required Before Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Shares Find Their Feet

There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues

Aug 15
There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues

Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively

Aug 12
Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively

Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)

Apr 08
Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)

Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital

Jan 24
Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital

Analyse CEO-vergoeding

Hoe is Liang Wang's beloning veranderd ten opzichte van Mediwelcome Healthcare Management & Technology's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-CN¥81m

Mar 31 2024n/an/a

-CN¥87m

Dec 31 2023CN¥691kCN¥600k

-CN¥94m

Sep 30 2023n/an/a

-CN¥86m

Jun 30 2023n/an/a

-CN¥79m

Mar 31 2023n/an/a

-CN¥84m

Dec 31 2022CN¥2mCN¥570k

-CN¥89m

Sep 30 2022n/an/a

-CN¥57m

Jun 30 2022n/an/a

-CN¥26m

Mar 31 2022n/an/a

-CN¥11m

Dec 31 2021CN¥3mCN¥650k

CN¥5m

Sep 30 2021n/an/a

CN¥6m

Jun 30 2021n/an/a

CN¥8m

Mar 31 2021n/an/a

CN¥14m

Dec 31 2020CN¥662kCN¥600k

CN¥21m

Sep 30 2020n/an/a

CN¥19m

Jun 30 2020n/an/a

CN¥16m

Mar 31 2020n/an/a

CN¥18m

Dec 31 2019CN¥665kCN¥573k

CN¥21m

Compensatie versus markt: De totale vergoeding ($USD 95.49K ) Liang } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 233.55K ).

Compensatie versus inkomsten: De vergoeding van Liang is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Liang Wang (48 yo)

5.2yrs

Tenure

CN¥691,000

Compensatie

Mr. Liang Wang serves as the Chief Executive Officer at Mediwelcome Healthcare Management & Technology Inc. and has been its Executive Director since September 18, 2019. Mr. Wang co-founded Mediwelcome Gro...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Wei Shi
Executive Chairman of the Board5.8yrsCN¥691.00k20.33%
HK$ 16.1m
Liang Wang
CEO & Executive Directorno dataCN¥691.00k6.02%
HK$ 4.8m
Weimin Yang
Executive Vice Chairman of the Board5.2yrsCN¥691.00k12.71%
HK$ 10.0m
Guijin Liu
CFO & Executive Directorno datageen gegevensgeen gegevens
Haidong Jiang
Chief Technology Officerno datageen gegevensgeen gegevens
Luyang Zhao
VP of Human Resources & Joint Company Secretary5.2yrsgeen gegevensgeen gegevens
Siu Wai Tsoi
Joint Company Secretary3.1yrsgeen gegevensgeen gegevens

5.2yrs

Gemiddelde duur

48yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 2159 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.2 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Wei Shi
Executive Chairman of the Board5.8yrsCN¥691.00k20.33%
HK$ 16.1m
Liang Wang
CEO & Executive Director5.2yrsCN¥691.00k6.02%
HK$ 4.8m
Weimin Yang
Executive Vice Chairman of the Board5.2yrsCN¥691.00k12.71%
HK$ 10.0m
Guijin Liu
CFO & Executive Directorless than a yeargeen gegevensgeen gegevens
Ruilin Song
Independent Non-Executive Director3.9yrsCN¥321.00kgeen gegevens
Zheng Wang
Independent Non-Executive Director3.9yrsCN¥229.00kgeen gegevens
Xiaoxi Yang
Independent Non-Executive Director3.9yrsCN¥227.00kgeen gegevens
Xia Liu
Non-Executive Director5.2yrsgeen gegevensgeen gegevens

4.5yrs

Gemiddelde duur

48yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 2159 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.5 jaar).